iTAg Tetramer/APC – HLA-A*02:01 Mart-1 (ELAGIGILTV)

The α3 mutation significantly reduces the binding of MHC tetramer to human CD8. To minimizes the aberrant effect of some CD8 antibodies; clone SFCI21Thy2D3 (also known as “T8”) is recommended.

Target: Cancer/Melanoma

Product Type: Tetramer

Application: FCM

Conjugate: APC

Class: Class I

Species Reactivity: Human

Allele: HLA-A*02:01

Peptide Sequence: ELAGIGILTV

Research Area: Immunology, Immune Monitoring

Protocols: FCM

Specificity: Mart-1

Storage Temperature: 4°C

Regulatory Statement: For Research Use Only. Not for use in diagnostic procedures.